SHANGHAI, 6 mai 2024 /PRNewswire/ — Henlius Biotech, Inc. (2696.HK) a annoncé que le partenaire commercial de la société, Accord BioPharma Inc. (la division spécialisée américaine d’Intas Pharmaceuticals, Ltd.), a reçu l’approbation de la Food and Drug Administration (FDA) des États-Unis…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.